Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age

Journal of Geriatric Oncology

Volumn 6, Issue 4, 2015, Pages 262-271

  Alibhai, Shabbir M H ^a,b,c   Breunis, Henriette ^a   Timilshina, Narhari ^a   Brignardello Petersen, Romina ^d   Tomlinson, George ^a,c,e   Mohamedali, Hassanabbas ^a   Gupta, Vikas ^a,b   Minden, Mark D ^a,b   Li, Madeline ^a   Buckstein, Rena ^b,f   Brandwein, Joseph M ^g  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CHILE   (Chile)

^e UNIVERSITY OF TORONTO   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acute myeloid leukemia; Aging; Chemotherapy; Depression; Physical function; Prospective study; Quality of life; Survivorship

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVOR; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TERTIARY CARE CENTER; TREND STUDY; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; DAILY LIFE ACTIVITY; EXERCISE TEST; FOLLOW UP; HAND STRENGTH; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA; SURVIVOR; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGE FACTORS; EXERCISE TEST; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HAND STRENGTH; HUMANS; LEUKEMIA, MYELOID, ACUTE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVORS; YOUNG ADULT;

EID: 84938987764     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2015.04.002     Document Type: Article

References (42)

1. Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J., et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001, 98(5):1312-1320.
2. Ferrara F., Schiffer C.A. Acute myeloid leukaemia in adults. Lancet 2013, 381(9865):484-495.
3. Estey E.H. General approach to, and perspectives on clinical research in, older patients with newly diagnosed acute myeloid leukemia. Semin Hematol 2006, 43(2):89-95.
4. Sawhney R., Sehl M., Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part I. Cancer J 2005, 11(6):449-460.
5. Sehl M., Sawhney R., Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part II. Cancer J 2005, 11(6):461-473.
6. Alibhai S.M., Leach M., Minden M.D., Brandwein J. Outcomes and quality of care in acute myeloid leukemia over 40years. Cancer 2009, 115(13):2903-2911.
7. Doria-Rose V.P., Harlan L.C., Stevens J., Little R.F. Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care Program. Leuk Lymphoma 2014, 55(11):2549-2555.
8. Stalfelt A.M. Quality of life during induction treatment of acute myeloid leukaemia. A comparison of three intensive chemotherapy regimens using three instruments for quality of life assessment. Acta Oncol 1994, 33(5):477-485.
9. Schumacher A., Kessler T., Buchner T., Wewers D., van de Loo J. Quality of life in adult patients with acute myeloid leukemia receiving intensive and prolonged chemotherapy - a longitudinal study. Leukemia 1998, 12(4):586-592.
10. Mohamedali H., Breunis H., Timilshina N., Brandwein J.M., Gupta V., Li M., et al. Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia. Leuk Res 2012, 36(10):1241-1248.
11. Derolf A.R., Kristinsson S.Y., Andersson T.M., Landgren O., Dickman P.W., Bjorkholm M. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 2009, 113(16):3666-3672.
12. Pulte D., Gondos A., Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 2008, 93(4):594-600.
13. Extermann M., Aapro M., Bernabei R., Cohen H.J., Droz J.P., Lichtman S., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55(3):241-252.
14. Brandwein J.M., Gupta V., Schuh A.C., Schimmer A.D., Yee K., Xu W., et al. Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy. Am J Hematol 2008, 83(1):54-58.
15. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-376.
16. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 1997, 34(3 Suppl. 2):13-19.
17. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
18. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrument activities of daily living. Gerontologist 1969, 9:179-186.
19. Mathiowetz V., Kashman N., Volland G., Weber K., Dowe M., Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985, 66(2):69-74.
20. Onder G., Penninx B.W., Ferrucci L., Fried L.P., Guralnik J.M., Pahor M. Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 2005, 60(1):74-79.
21. Rantanen T., Volpato S., Ferrucci L., Heikkinen E., Fried L.P., Guralnik J.M. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc 2003, 51(5):636-641.
22. Finch E., Brooks D., Stratford P., Mayo N. Physical Rehabilitation Outcome Measures II 2002, Canadian Physiotherapy Association, Toronto, [292pp.]. 2nd ed.
23. Solway S., Brooks D., Lacasse Y., Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001, 119(1):256-270.
24. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166(1):111-117.
25. McArdle W.D., Katch F.I., Pechar G.S., Jacobson L., Ruck S. Reliability and interrelationships between maximal oxygen intake, physical work capacity and step-test scores in college women. Med Sci Sports Exerc 1972, 4(4):182-186.
26. Csuka M., McCarty D.J. Simple method for measurement of lower extremity muscle strength. Am J Med 1985, 78(1):77-81.
27. Osoba D., Rodrigues G., Myles J., Zee B., Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16(1):139-144.
28. Cella D., Eton D.T., Lai J.S., Peterman A.H., Merkel D.E. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002, 24(6):547-561.
29. Norman G.R., Sloan J.A., Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41(5):582-592.
30. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1(1):43-46.
31. Donaldson G.W., Moinpour C.M. Learning to live with missing quality-of-life data in advanced-stage disease trials. J Clin Oncol 2005, 23(30):7380-7384.
32. Fairclough D.L. Analysing studies with missing data. Assessing quality of life in clinical trials: methods and practice 2005, Oxford University Press, Oxford. 2nd ed. P. Fayers, R. Hays (Eds.).
33. Brandwein J.M., Geddes M., Kassis J., Kew A.K., Leber B., Nevill T., et al. Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus. Am J Blood Res 2013, 3(2):141-164.
34. Cooper R., Kuh D., Hardy R. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 2010, 341:c4467.
35. Stalfelt A.M. Quality of life of patients with acute myeloid leukaemia. Leuk Res 1994, 18(4):257-267.
36. Schumacher A., Wewers D., Heinecke A., Sauerland C., Koch O.M., van de Loo J., et al. Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia. Leuk Res 2002, 26(4):355-362.
37. Alibhai S.M.H., Leach M., Kermalli H., Gupta V., Kowgier M.E., Tomlinson G.A., et al. The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults. Crit Rev Oncol Hematol 2007, 64:19-30.
38. Chang P.H., Lai Y.H., Shun S.C., Lin L.Y., Chen M.L., Yang Y., et al. Effects of a walking intervention on fatigue-related experiences of hospitalized acute myelogenous leukemia patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage 2008, 35(5):524-534.
39. Battaglini C.L., Hackney A.C., Garcia R., Groff D., Evans E., Shea T. The effects of an exercise program in leukemia patients. Integr Cancer Ther 2009, 8(2):130-138.
40. Klepin H.D., Danhauer S.C., Tooze J.A., Stott K., Daley K., Vishnevsky T., et al. Exercise for older adult inpatients with acute myelogenous leukemia: a pilot study. J Geriatr Oncol 2011, 2(1):11-17.
41. Alibhai S.M., O'Neill S., Fisher-Schlombs K., Breunis H., Brandwein J.M., Timilshina N., et al. A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy. Leuk Res 2012, 36(10):1255-1261.
42. Gupta V., Chun K., Yi Q.L., Minden M., Schuh A., Wells R., et al. Disease biology rather than age is the most important determinant of survival of patients > or =60years with acute myeloid leukemia treated with uniform intensive therapy. Cancer 2005, 103(10):2082-2090.